(Q36899187)

17 August 2017

1 reference

title

Glimepiride: role of a new sulfonylurea in the treatment of type 2 diabetes mellitus (English)

1 reference

17 August 2017

1 reference

R K Campbell

1

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

Annals of Pharmacotherapy

17 August 2017

published in

1 reference

17 August 2017

volume

32

1 reference

17 August 2017

issue

10

1 reference

17 August 2017

page(s)

1044-1052

1 reference

The Achilles heel of the University Group Diabetes Program

17 August 2017

cites work

1 reference

Haemodynamic and other effects of sulphonylurea drugs on the heart

21 January 2018

1 reference

Cardiovascular effects of conventional sulfonylureas and glimepiride

21 January 2018

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

21 January 2018

1 reference

21 January 2018

1 reference

The beta-cell response to oral hypoglycemic agents

21 January 2018

1 reference

K+ channels: generating excitement in pancreatic beta-cells

21 January 2018

1 reference

Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. II. Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride

21 January 2018

1 reference

The molecular interaction of sulfonylureas with beta-cell ATP-sensitive K(+)-channels.

21 January 2018

1 reference

Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics

21 January 2018

1 reference

Extrapancreatic effects of sulfonylureas--a comparison between glimepiride and conventional sulfonylureas.

21 January 2018

1 reference

Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at adipocytes

21 January 2018

1 reference

The sulfonylurea drug, glimepiride, stimulates glucose transport, glucose transporter translocation, and dephosphorylation in insulin-resistant rat adipocytes in vitro

21 January 2018

1 reference

Stimulation of glucose utilization in 3T3 adipocytes and rat diaphragm in vitro by the sulphonylureas, glimepiride and glibenclamide, is correlated with modulations of the cAMP regulatory cascade.

21 January 2018

1 reference

Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide

21 January 2018

1 reference

Clinical profile of glimepiride

21 January 2018

1 reference

Glimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients. Glimepiride Study Group.

21 January 2018

1 reference

Short-term comparison of once- versus twice-daily administration of glimepiride in patients with non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

Pharmacokinetic basis for the safety of glimepiride in risk groups of NIDDM patients

21 January 2018

1 reference

A dose-response study of glimepiride in patients with NIDDM who have previously received sulfonylurea agents. The Glimepiride Protocol #201 Study Group.

21 January 2018

1 reference

Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group.

21 January 2018

1 reference

Combined therapy with a sulfonylurea plus evening insulin: safe, reliable, and becoming routine

21 January 2018

1 reference

Combination insulin-sulfonylurea therapy

21 January 2018

1 reference

Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.

21 January 2018

1 reference

How often is medication taken as prescribed? A novel assessment technique

21 January 2018

1 reference

Combination of oral antidiabetic drugs and insulin in the treatment of non-insulin-dependent diabetes

21 January 2018

1 reference

New and traditional treatment of glycemia in NIDDM

21 January 2018

1 reference

Adenosine triphosphate-dependent K currents activated by metabolic inhibition in rat ventricular myocytes differ from those elicited by the channel opener rilmakalim

21 January 2018

1 reference

Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans

21 January 2018

1 reference

The pharmacological treatment of hyperglycemia in NIDDM. American Diabetes Association

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.17360

1 reference

17 August 2017

1 reference